Skip to content

DENTEPHARMA

Absorbed by Dentius BV KBO/BCE: BE 0548.701.977 subsidiary of Dentcap
DENTEPHARMA
Financial year 2022
Follow Report

Annual accounts 2022

abbreviated format, filed on 28-08-2023, 28 days late
-€4,986
▼ €295,828
-€19,994
▼ €293,442
-€47,635
▼ €322,656
€115,466
▲ €445,523
78.5%
▲ 0.5 percentage points
26.09
▲ 25.73

Turnover: not included in this filing.

Balance sheet

balance sheet total €2.4m on 31-12-2022
What the company ownsHow it is paid for

in €m

in euro

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20222021202020192018201720162015
Balance sheet: assets
20/58 2.4m2.5m2.5m2.7m2.7m2.5m2.5m2.5m
21/28 2.3m2.3m2.4m2.4m2.4m2.3m2.3m2.3m
21 28,57142,85757,14371,42985,714---
22/27 ---6741,6882,225--
23 ----5971,194--
24 ---6741,0911,031--
28 2.3m2.3m2.3m2.3m2.3m2.3m2.3m2.3m
29/58 120,068181,876109,369346,617295,870246,418160,568152,539
29 ------63,55386,842
291 ------63,55386,842
40/41 119,899155,50593,215320,175266,063223,07567,93717,381
41 119,899155,50593,215320,175266,063223,07567,93717,381
54/58 16926,30015,61325,11226,9008,34129,07748,317
490/1 -715421,3302,90715,002--
Balance sheet: equity and liabilities
10/49 2.4m2.5m2.5m2.7m2.7m2.5m2.5m2.5m
10/15 1.9m2.0m2.0m1.7m1.7m1.2m904,484508,019
10/11 248,600248,600248,600248,600248,600248,600248,600248,600
10 248,600248,600------
100 248,600248,600248,600248,600248,600248,600248,600248,600
13 1.7m1.7m1.7m1.5m1.4m983,860654,860254,860
130/1 224,860224,860224,860200,000200,000200,000--
130 24,86024,86024,86024,86024,86024,86024,86024,860
1319 200,000200,000200,000200,000200,000200,000--
133 1.5m1.5m1.5m1.2m1.2m759,000630,000230,000
14 -44,6602,9752,9751,5461,2924581,0244,559
17/49 526,839555,299497,0771.0m1.0m1.3m1.6m1.9m
17 507,02620,000112,993171,639489,807800,2161.1m1.5m
170/4 507,02620,000112,993171,639489,807800,2161.1m1.5m
42/48 4,603511,934383,389806,294513,919492,521433,773391,251
42 -112,589369,370464,944455,633445,849416,210291,169
43 -120,000------
439 -120,000------
44 4,6034,2983,4423,3963,2942,5583632,261
440/4 4,6034,2983,4423,3963,2942,5583632,261
45 --9,45461,70454,99244,11317,20097,585
450/3 --9,45458,20451,49244,11317,20097,585
454/9 ---3,5003,500---
47/48 -275,0471,123276,250---236
492/3 15,21123,36569522,78023,79522,98923,00422,929
Income statement
76A -16,774------
9900 -4,986290,842349,832560,943606,473556,961675,969455,325
630 14,28614,28614,96016,64816,3381,295--
640/8 3183,1087128427920789-
66A 404-------
9901 -19,994273,448334,801544,010589,855555,460675,880455,325
75/76B -10,95515,53334,11930,31419,6275,3304,259
75 -10,95515,53334,11930,31419,6275,3304,259
65/66B 17,7079,38214,41021,42129,95642,53980,53366,572
65 17,7079,38214,41021,42129,95642,53980,53366,572
9903 -37,702275,021335,923556,708590,213532,547600,676393,012
67/77 9,933-84,495169,454167,379204,113204,212133,593
9904 -47,635275,021251,428387,254422,834328,434396,464259,419
9905 -47,635275,021251,428387,254422,834328,434396,464259,419
Appropriation of the result
9906 -44,660277,996252,975388,546423,292329,458401,024259,419
14P 2,9752,975------
691/2 --250,00062,000422,000329,000400,000254,860
6920 -------24,860
6921 --250,00062,000422,000329,000400,000230,000
694/7 -275,021-325,000----
694 ---325,000----
695 -275,021------
Document PDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 12 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2022 (PDF), filed on 28-08-2023.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2022 annual accounts filed 28 days after the deadline. Filed on 28 August 2023, deadline 31 July 2023 (7 months after the close on 31 December 2022, Companies Code art. 3:10). Source: NBB, 2023-00431415.

Financial year Type Filed Reference Document
31-12-2022 abbreviated format 28-08-2023 2023-00431415 PDF
31-12-2021 abbreviated format 30-09-2022 2022-20452258 PDF
31-12-2020 full format 25-06-2021 2021-25200202 PDF
31-12-2019 full format 31-08-2020 2020-48600250 PDF
31-12-2018 full format 26-08-2019 2019-53700276 PDF
31-12-2017 full format 23-07-2018 2018-36600313 PDF
31-12-2016 full format 30-06-2017 2017-25100518 PDF
30-06-2015 full format 13-01-2016 2016-01900404 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20222021202020192018201720162015
-5,708287,734349,761560,658606,194556,755--
-33,349289,307266,389403,902439,172329,729--
0001,349101,5153,520-2.3m
-26,13110,688-9,499-1,78818,559-20,736-19,240-
115,466-330,058-274,020-459,677-218,049-246,102-273,206-238,711
78.5%78.0%79.8%63.2%61.7%48.4%36.8%20.7%
26.090.360.290.430.580.500.370.39
0.270.280.250.580.621.071.723.83
-2.5%14.0%12.8%22.5%25.5%26.6%43.8%51.1%
-1.9%10.9%10.2%14.2%15.8%12.9%16.1%10.6%
-0.3230.67------

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on DENTEPHARMA

The operating result for 2022 is a loss of €19,994, after a profit of €273,448 in 2021. It is the lowest result since 2015.

Debt's share of the balance-sheet total falls from 22.0% to 21.5%. Equity and debt are lower.

We would like to set cookies. That happens only with your consent. What we measure